Abstract
In 2018, an estimated 7.8% of individuals with diabetes who owned a smartphone used a diabetes app to support self-management.1 A meta-analysis found that using an app supporting blood glucose self-management was associated with a hemoglobin A1c (HbA1c) reduction of 0.5%.2 As most diabetes apps fall outside US Food and Drug Administration regulation, intended effect and clinical safety are not ensured.3 Previous studies of diabetes apps described features, privacy and security, and usability.4 This study analyzed key management features, namely decision support and alerts for self-management of blood glucose in type 2 diabetes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
